$BIIB
BIOGEN INC. Stock $biib

$biib Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-Q Financial Statement

#000087504519000017 Filed on April 24, 2019

Income Statement

Concept	2019 Q1	2018 Q1
Revenue	$3.490B	$3.131B
YoY Change	11.46%	11.4%
Cost Of Revenue	$602.0M	$446.0M
YoY Change	34.98%	15.96%
Gross Profit	$2.888B	$2.685B
YoY Change	7.55%	10.68%
Gross Profit Margin	82.75%	85.76%
Selling, General & Admin	$567.7M	$501.3M
YoY Change	13.25%	0.52%
% of Gross Profit	19.66%	18.67%
Research & Development	$563.7M	$496.7M
YoY Change	13.49%	17.31%
% of Gross Profit	19.52%	18.5%
Depreciation & Amortization	$121.1M	$168.9M
YoY Change	-28.3%	-67.01%
% of Gross Profit	4.19%	6.29%
Operating Expenses	$1.131B	$998.0M
YoY Change	13.37%	8.23%
Operating Profit	$1.503B	$1.535B
YoY Change	-2.09%	49.77%
Interest Expense	$47.90M	$50.50M
YoY Change	-5.15%	-20.35%
% of Operating Profit	3.19%	3.29%
Other Income/Expense, Net	$357.3M	-$41.00M
YoY Change	-971.46%	7.89%
Pretax Income	$1.860B	$1.494B
YoY Change	24.52%	51.38%
Income Tax	$422.5M	$322.5M
% Of Pretax Income	22.72%	21.59%
Net Earnings	$1.409B	$1.173B
YoY Change	20.11%	56.89%
Net Earnings / Revenue	40.37%	37.46%
Basic Earnings Per Share	$7.17	$5.55
Diluted Earnings Per Share	$7.15	$5.54
COMMON SHARES
Basic Shares Outstanding	196.6M shares	211.4M shares
Diluted Shares Outstanding	197.0M shares	211.7M shares

Balance Sheet

Concept	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.909B	$5.916B
YoY Change	-33.92%	105.42%
Cash & Equivalents	$2.243B	$4.108B
Short-Term Investments	$1.666B	$1.808B
Other Short-Term Assets	$965.4M	$895.9M
YoY Change	7.76%	-27.27%
Inventory	$770.2M	$890.8M
Prepaid Expenses
Receivables	$2.089B	$1.939B
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$8.943B	$10.20B
YoY Change	-12.29%	48.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.014B	$3.335B
YoY Change	-9.62%	27.72%
Goodwill	$5.640B	$4.908B
YoY Change	14.91%	35.89%
Intangibles	$3.056B	$3.795B
YoY Change	-19.46%	-7.54%
Long-Term Investments	$3.236B	$1.580B
YoY Change	104.81%	-60.56%
Other Assets	$1.898B	$380.1M
YoY Change	399.42%	-67.91%
Total Long-Term Assets	$17.50B	$15.89B
YoY Change	10.12%	10.87%
TOTAL ASSETS
Total Short-Term Assets	$8.943B	$10.20B
Total Long-Term Assets	$17.50B	$15.89B
Total Assets	$26.45B	$26.09B
YoY Change	1.36%	23.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$378.0M	$345.8M
YoY Change	9.31%	9.29%
Accrued Expenses	$1.436B	$1.217B
YoY Change	18.0%	26.38%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due		$3.000M
YoY Change		-99.47%
Total Short-Term Liabilities	$3.149B	$3.152B
YoY Change	-0.11%	5.33%
LONG-TERM LIABILITIES
Long-Term Debt	$5.943B	$5.929B
YoY Change	0.24%	-0.4%
Other Long-Term Liabilities	$1.354B	$1.640B
YoY Change	-17.45%	138.1%
Total Long-Term Liabilities	$1.354B	$1.640B
YoY Change	-17.45%	138.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.149B	$3.152B
Total Long-Term Liabilities	$1.354B	$1.640B
Total Liabilities	$12.62B	$12.05B
YoY Change	4.74%	23.89%
SHAREHOLDERS EQUITY
Retained Earnings	$17.03B	$17.33B
YoY Change	-1.78%	17.27%
Common Stock	$100.0K	$100.0K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.977B	$2.977B
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	$13.83B	$14.05B
YoY Change
Total Liabilities & Shareholders Equity	$26.45B	$26.09B
YoY Change	1.36%	23.09%

Cashflow Statement

Concept	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	$1.409B	$1.173B
YoY Change	20.11%	56.89%
Depreciation, Depletion And Amortization	$121.1M	$168.9M
YoY Change	-28.3%	-67.01%
Cash From Operating Activities	$1.460B	$1.457B
YoY Change	0.16%	519.52%
INVESTING ACTIVITIES
Capital Expenditures	$127.1M	$194.7M
YoY Change	-34.72%	-7.29%
Acquisitions
YoY Change
Other Investing Activities	-$1.700M	-$1.600M
YoY Change	6.25%	-124.24%
Cash From Investing Activities	$238.8M	$1.347B
YoY Change	-82.27%	-280.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$655.8M	$250.0M
YoY Change	162.32%	-57.16%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$679.3M	-$268.6M
YoY Change	152.9%	-70.2%
NET CHANGE
Cash From Operating Activities	$1.460B	$1.457B
Cash From Investing Activities	$238.8M	$1.347B
Cash From Financing Activities	-$679.3M	-$268.6M
Net Change In Cash	$1.019B	$2.535B
YoY Change	-59.8%	-279.74%
FREE CASH FLOW
Cash From Operating Activities	$1.460B	$1.457B
Capital Expenditures	$127.1M	$194.7M
Free Cash Flow	$1.332B	$1.262B
YoY Change	5.54%	4909.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	biib	Adjustments To Product Revenue Reserves Relating To Sales In Prior Years AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears	24500000	USD
CY2018Q4	biib	Available For Sale Securities Debt Maturities After Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost	143500000	USD
CY2019Q1	biib	Available For Sale Securities Debt Maturities After Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost	135000000	USD
CY2018Q4	biib	Available For Sale Securities Debt Maturities After Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue	143200000	USD
CY2019Q1	biib	Available For Sale Securities Debt Maturities After Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue	134900000	USD
CY2019Q1	biib	Average Maturity Of Marketable Securities AverageMaturityOfMarketableSecurities	P12M
CY2018Q4	biib	Collaborationexpensesaccrual Collaborationexpensesaccrual	261600000	USD
CY2019Q1	biib	Collaborationexpensesaccrual Collaborationexpensesaccrual	216600000	USD
CY2018Q1	biib	Collaborationprofitlosssharing Collaborationprofitlosssharing	42500000	USD
CY2019Q1	biib	Collaborationprofitlosssharing Collaborationprofitlosssharing	58100000	USD
CY2019Q1	biib	Current Provisions To Product Revenue Reserves Relating To Sales In Current Year CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear	826200000	USD
CY2018Q4	biib	Duefromanti Cd20therapeuticprograms DuefromantiCD20therapeuticprograms	526900000	USD
CY2019Q1	biib	Duefromanti Cd20therapeuticprograms DuefromantiCD20therapeuticprograms	527100000	USD
CY2018Q1	biib	Effective Tax Rate Reconciliation Gilt Itax EffectiveTaxRateReconciliationGILTItax	0.013
CY2019Q1	biib	Effective Tax Rate Reconciliation Gilt Itax EffectiveTaxRateReconciliationGILTItax	0.019
CY2019Q1	biib	Interest In Subsidiary InterestInSubsidiary	1.00
CY2018Q4	biib	Inventorynetcurrentandnoncurrent Inventorynetcurrentandnoncurrent	936500000	USD
CY2019Q1	biib	Inventorynetcurrentandnoncurrent Inventorynetcurrentandnoncurrent	770200000	USD
CY2018Q4	biib	Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities	28700000	USD
CY2019Q1	biib	Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities	112200000	USD
CY2018Q4	biib	Net Minimum Lease Payments NetMinimumLeasePayments	418800000	USD
CY2018Q4	biib	Net Minimum Lease Payments Thereafter NetMinimumLeasePaymentsThereafter	156900000	USD
CY2018Q4	biib	Net Minimum Lease Payments With In Five Year NetMinimumLeasePaymentsWithInFiveYear	46700000	USD
CY2018Q4	biib	Net Minimum Lease Payments With In Four Year NetMinimumLeasePaymentsWithInFourYear	47700000	USD
CY2018Q4	biib	Net Minimum Lease Payments With In One Year NetMinimumLeasePaymentsWithInOneYear	60200000	USD
CY2018Q4	biib	Net Minimum Lease Payments With In Three Year NetMinimumLeasePaymentsWithInThreeYear	52200000	USD
CY2018Q4	biib	Net Minimum Lease Payments With In Two Year NetMinimumLeasePaymentsWithInTwoYear	55100000	USD
CY2019Q1	biib	Noncontrollinginterestincreasedecreaseother Noncontrollinginterestincreasedecreaseother	100000	USD
CY2019Q1	biib	Payments Returns Applied Against Product Revenue Reserves Relating To Current Year PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear	294800000	USD
CY2019Q1	biib	Payments Returns Applied Against Product Revenue Reserves Relating To Prior Year PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear	474800000	USD
CY2018Q1	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	47000000	USD
CY2019Q1	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	46200000	USD
CY2018Q4	biib	Unrealized Gain Losses On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax	27300000	USD
CY2019Q1	biib	Unrealized Gain Losses On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax	-44300000	USD
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2018Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	791400000	USD
CY2019Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	796100000	USD
CY2018Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	224700000	USD
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000875045
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	193893397	shares
CY2019Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	195000000	USD
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1841000000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-318400000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1797400000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2088900000	USD
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	BIOGEN INC.
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	370500000	USD
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	378000000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1958500000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-303900000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-240400000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-219800000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-316900000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	0	USD
CY2019Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	0	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	46700000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	49000000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	50400000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	49500000	USD
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	103900000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	68200000	USD
CY2019Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2018Q4	us-gaap	Assets Assets	25288900000	USD
CY2019Q1	us-gaap	Assets Assets	26445500000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	7640900000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	8942600000	USD
CY2018Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	0	USD
CY2019Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	682000000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1300000	USD
CY2019Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	4600000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	6000000	USD
CY2019Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1200000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	3694000000	USD
CY2019Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	3035100000	USD
CY2018Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	3689300000	USD
CY2019Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	3038500000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1235900000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1234800000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1232700000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1237800000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	2314600000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	1665300000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	2313400000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	1665800000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	3689300000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	3038500000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1224600000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2243200000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2535100000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	444800000	USD
CY2019Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	147300000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	2313400000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	1665800000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	1375900000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	1372700000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	265000000	USD
CY2019Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	274000000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1573800000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4108000000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1019000000	USD
CY2018Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	705500000	USD
CY2019Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1881900000	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	100000	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	100000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1185900000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1429400000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1700000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1184200000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1429400000	USD
CY2018Q4	us-gaap	Construction Payable Current And Noncurrent ConstructionPayableCurrentAndNoncurrent	125200000	USD
CY2019Q1	us-gaap	Construction Payable Current And Noncurrent ConstructionPayableCurrentAndNoncurrent	99700000	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	446000000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	602000000	USD
CY2018Q1	us-gaap	Costs And Expenses CostsAndExpenses	1596400000	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	1987100000	USD
CY2018Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	6037600000	USD
CY2019Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	6155800000	USD
CY2018Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	1800000	USD
CY2019Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	600000	USD
CY2018Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	9400000	USD
CY2019Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	300000	USD
CY2018Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	53100000	USD
CY2019Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	228000000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	2153900000	USD
CY2019Q1	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	2074400000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1636200000	USD
CY2019Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1741700000	USD
CY2018Q1	us-gaap	Depreciation Depreciation	65000000	USD
CY2019Q1	us-gaap	Depreciation Depreciation	52900000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	168900000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	121100000	USD
CY2019Q1	us-gaap	Disposal Group Including Discontinued Operation Other Expense DisposalGroupIncludingDiscontinuedOperationOtherExpense	10000000	USD
CY2018Q4	us-gaap	Disposal Group Including Discontinued Operation Other Liabilities DisposalGroupIncludingDiscontinuedOperationOtherLiabilities	0	USD
CY2019Q1	us-gaap	Disposal Group Including Discontinued Operation Other Liabilities DisposalGroupIncludingDiscontinuedOperationOtherLiabilities	97200000	USD
CY2018Q1	us-gaap	Disposal Group Not Discontinued Operation Loss Gain On Write Down DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown	0	USD
CY2019Q1	us-gaap	Disposal Group Not Discontinued Operation Loss Gain On Write Down DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown	115500000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.55
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.17
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.54
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	7.15
CY2018Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-900000	USD
CY2019Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-400000	USD
CY2018Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.216
CY2019Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.227
CY2018Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2018Q1	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	0
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	0.043
CY2018Q1	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.020
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.046
CY2018Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.006
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.003
CY2018Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.004
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.004
CY2018Q1	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.002
CY2018Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.009
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.004
CY2018Q1	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.008
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.008
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	320900000	USD
CY2019Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	160800000	USD
CY2018Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	3400000	USD
CY2019Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	3300000	USD
CY2018Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	7600000	USD
CY2019Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	7400000	USD
CY2018Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	0	USD
CY2019Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	375000000	USD
CY2018Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	5600000	USD
CY2019Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-11500000	USD
CY2018Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	20000000	USD
CY2019Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	0	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4607300000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4675600000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	290000000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	200000000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	190000000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	230000000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	250000000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	250000000	USD
CY2018Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1000000	USD
CY2019Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2200000	USD
CY2018Q4	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions FutureMinimumSubleaseRentalsSaleLeasebackTransactions	182800000	USD
CY2018Q4	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Thereafter FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter	58400000	USD
CY2018Q4	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within Five Years FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFiveYears	24300000	USD
CY2018Q4	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within Four Years FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFourYears	24000000	USD
CY2018Q4	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within One Year FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear	26800000	USD
CY2018Q4	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within Three Years FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears	23700000	USD
CY2018Q4	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within Two Years FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears	25600000	USD
CY2018Q1	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-5600000	USD
CY2019Q1	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	4800000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	5706400000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	5639700000	USD
CY2019Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	USD
CY2019Q1	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	2800000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1493700000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1860000000	USD
CY2018Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-28700000	USD
CY2018Q1	us-gaap	Income Loss From Individually Significant Component Disposed Of Or Held For Sale Excluding Discontinued Operations Attributable To Parent Before Income Tax IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsAttributableToParentBeforeIncomeTax	0	USD
CY2019Q1	us-gaap	Income Loss From Individually Significant Component Disposed Of Or Held For Sale Excluding Discontinued Operations Attributable To Parent Before Income Tax IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsAttributableToParentBeforeIncomeTax	-115500000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	322500000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	422500000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	134000000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	136600000	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	257600000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	170300000	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-121800000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-138400000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2600000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-129000000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	20000000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	171100000	USD
CY2018Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	7727300000	USD
CY2019Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	7731800000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3120000000	USD
CY2019Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3056200000	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	50500000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	47900000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	133500000	USD
CY2019Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	108200000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	929900000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	770200000	USD
CY2018Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	6600000	USD
CY2019Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	0	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	196300000	USD
CY2019Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	199700000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	606700000	USD
CY2019Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	462300000	USD
CY2018Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	26700000	USD
CY2019Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	31200000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	577200000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	146200000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	81700000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	66100000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	68600000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	69200000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	76000000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	69400000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	68600000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	12257300000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	12623500000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25288900000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26445500000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3295200000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3148700000	USD
CY2018Q4	us-gaap	Long Term Debt LongTermDebt	5936500000	USD
CY2019Q1	us-gaap	Long Term Debt LongTermDebt	5943200000	USD
CY2018Q4	us-gaap	Minority Interest MinorityInterest	-8000000	USD
CY2019Q1	us-gaap	Minority Interest MinorityInterest	-7900000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-268600000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-679300000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1346600000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	238800000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1457100000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1459500000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	1172900000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	1408800000	USD
CY2018Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1700000	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-41000000	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	357300000	USD
CY2018Q4	us-gaap	Notes Payable NotesPayable	5936500000	USD
CY2019Q1	us-gaap	Notes Payable NotesPayable	5943200000	USD
CY2019Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1534700000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1502700000	USD
CY2019Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	15700000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	508600000	USD
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	436100000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	19400000	USD
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	447800000	USD
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0333
CY2019Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y10M18D
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	601600000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	87000000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	71000000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	71700000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	75900000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	80700000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	215300000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	609300000	USD
CY2019Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	708000000	USD
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	687600000	USD
CY2019Q1	us-gaap	Other Assets Current OtherAssetsCurrent	965400000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1690600000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1898300000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2200000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	6900000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-24400000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	37300000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-29000000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	16900000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	44700000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-17800000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	13200000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	20600000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	13000000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	20600000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	500000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-600000	USD
CY2018Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2861200000	USD
CY2019Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2435000000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1389400000	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1353800000	USD
CY2018Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-31700000	USD
CY2019Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-50700000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1800000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-200000	USD
CY2018Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1600000	USD
CY2019Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1700000	USD
CY2018Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	250000000	USD
CY2019Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	655800000	USD
CY2018Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	21200000	USD
CY2019Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	32200000	USD
CY2018Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	1919200000	USD
CY2019Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	825000000	USD
CY2018Q1	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	10000000	USD
CY2019Q1	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	0	USD
CY2018Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	600000000	USD
CY2019Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	300000000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	194700000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	127100000	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	2600000	USD
CY2019Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	8700000	USD
CY2018Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	4068900000	USD
CY2019Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	1489200000	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	1171200000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	1408800000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3601200000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3013800000	USD
CY2018Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-14400000	USD
CY2019Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	376400000	USD
CY2018Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	37400000	USD
CY2019Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-16700000	USD
CY2018Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	496700000	USD
CY2019Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	563700000	USD
CY2018Q1	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	10000000	USD
CY2019Q1	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2018Q1	us-gaap	Restructuring Charges RestructuringCharges	1600000	USD
CY2019Q1	us-gaap	Restructuring Charges RestructuringCharges	400000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	16257000000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	17026700000	USD
CY2018Q1	us-gaap	Revenues Revenues	3131100000	USD
CY2019Q1	us-gaap	Revenues Revenues	3489800000	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5400000	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	501300000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	567700000	USD
CY2019Q1	us-gaap	Servicing Asset At Fair Value Description Of Changes In Valuation Inputs ServicingAssetAtFairValueDescriptionOfChangesInValuationInputs	0
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	43400000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	45700000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	37800000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	48900000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	16200000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	16600000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	12612800000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	14053700000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	13039600000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	13829900000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12598100000	USD
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14037500000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13031600000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13822000000	USD
CY2018Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	479900000	USD
CY2018Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	63500000	USD
CY2019Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	238500000	USD
CY2018Q1	us-gaap	Translation Adjustment For Net Investment Hedge Net Of Tax Period Increase Decrease TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease	0	USD
CY2019Q1	us-gaap	Translation Adjustment For Net Investment Hedge Net Of Tax Period Increase Decrease TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease	14000000	USD
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2977100000	USD
CY2019Q1	us-gaap	Treasury Stock Value TreasuryStockValue	2977100000	USD
CY2018Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1051300000	USD
CY2019Q1	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1083400000	USD
CY2018Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	300000	shares
CY2019Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	400000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	211700000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	197000000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	211400000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	196600000	shares
CY2019Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The preparation of our condensed consolidated financial statements requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis we evaluate our estimates, judgments and methodologies. We base our estimates on historical experience and on various other assumptions that we believe are reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity and the amount of revenues and expenses. Actual results may differ from these estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0000875045-19-000017-index-headers.html	Edgar Link	pending
0000875045-19-000017-index.html	Edgar Link	pending
0000875045-19-000017.txt	Edgar Link	pending
0000875045-19-000017-xbrl.zip	Edgar Link	pending
amortofacquireintanassets.jpg	Edgar Link	pending
anticd20revenues.jpg	Edgar Link	pending
biib-20190331.xml	Edgar Link	completed
biib-20190331.xsd	Edgar Link	pending
biib-20190331_cal.xml	Edgar Link	unprocessable
biib-20190331_def.xml	Edgar Link	unprocessable
biib-20190331_lab.xml	Edgar Link	unprocessable
biib-20190331_pre.xml	Edgar Link	unprocessable
biib-2019331x10q.htm	Edgar Link	pending
biib-2019331xex101.htm	Edgar Link	pending
biib-2019331xex311.htm	Edgar Link	pending
biib-2019331xex312.htm	Edgar Link	pending
biib-2019331xex321.htm	Edgar Link	pending
biogenlogostandardrgbr.jpg	Edgar Link	pending
biosimilars.jpg	Edgar Link	pending
collabprofitshare.jpg	Edgar Link	pending
costofsales.jpg	Edgar Link	pending
equityinlossofinvestee.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
financialhighlights.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fvonremeasurementofcc.jpg	Edgar Link	pending
incometaxprovision.jpg	Edgar Link	pending
interferon.jpg	Edgar Link	pending
lossonheldforsale.jpg	Edgar Link	pending
oie.jpg	Edgar Link	pending
otherrevenue.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
rdandpercentofrevenue.jpg	Edgar Link	pending
report.css	Edgar Link	pending
researchanddev.jpg	Edgar Link	pending
reservesfordisandallow.jpg	Edgar Link	pending
sganda.jpg	Edgar Link	pending
Show.js	Edgar Link	pending
spinraza.jpg	Edgar Link	pending
tecfidera.jpg	Edgar Link	pending
tysabri.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BIIB
BIOGEN INC. Stock $biib

2019 Q1 Form 10-Q Financial Statement

#000087504519000017 Filed on April 24, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIIB BIOGEN INC. Stock $biib

2019 Q1 Form 10-Q Financial Statement

#000087504519000017 Filed on April 24, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIIB
BIOGEN INC. Stock $biib